close icon

Synchrony Financial Draws Bullish Elliott Wave Pattern

Synchrony Financial spun off from General Electric less than five years ago, but its shareholders have already experienced plenty of market turbulence on their own. 2018, for example, was nothing to brag about. The stock plunged from an all-time high of $40.59 in January to as low as $21.78 in late December.

And as it often happens, the best gains in the stock market come to those who have the courage to buy after a big selloff. Synchrony Financial stock closed at $31.90 last month, up over 46% from the December low. The Elliott Wave structure of this rally is of big interest to us.

Synchrony Financial stock Elliott Wave pattern

The 1-hour chart of SYF stock reveals that the surge from $21.78 to $33.56 is a textbook five-wave impulse. Wave 1 is extended, but wave 3 is still longer than wave 5, so there is no violation of the rule stating that wave 3 cannot be the shortest among waves 1, 3 and 5.

Synchrony Financial Looks Strong

According to the Wave theory, impulses point in the direction of the larger trend. This means that once the corresponding three-wave pullback in wave (2/B) is over, the bulls can be expected to return in wave (3/C). In the long run, we would not be surprised to see Synchrony Financial near $40 a share again.

Besides, it is not just Elliott Wave analysis that makes this stock look promising. Synchrony is the leading provider of private label credit cards in the United States. The company is consistently profitable, conservatively financed and growing. Its 2018 price to earnings ratio of 8.5 suggests it is undervalued, as well.

Technical and fundamental analysis don’t always point in the same direction, but when they do, it is a risk worth taking.

Did you like this analysis? Similar Elliott Wave setups occur in the Forex, crypto and commodities markets, as well. Our Elliott Wave Video Course can teach you how to uncover them yourself!

Disclosure: the author holds a long position in Synchrony Financial stock.



Stay informed with our newsletter

Latest Elliott Wave analysis on different topics delivered to you weekly.

Privacy policy
You may also like:

Shopify is One of Many Bubble Stocks Out There

It is becoming pretty clear that a speculative bubble is inflating right now. Money-losing companies with market caps in the tens and even hundreds of billions of dollars have become the norm, not the exception. People, who have been in the market for just a couple of months are bragging online about the phenomenal returns…

Read More »

Undervalued Bristol Myers Stock Can Still Get Cheaper

It’s been almost two years since we shared our bullish stance on Bristol Myers stock. Shares in the pharmaceutical major were changing hands for less than $46 in April, 2019. The company had just announced its planned acquisition of Celgene for about $74 billion and Wall Street apparently didn’t like the risks involved. However, the…

Read More »

DraftKings on the Verge of Another 40% Decline

It’s been almost three and a half months since we examined DraftKings stock in October, 2020. The share price was hovering near $57 after a strong run from $10.60 to over $64 in just several months. The regulatory environment in the U.S. seemed to be warming up and many analysts hurried to issue their BUY…

Read More »

AMN Healthcare Stock to Suffer a 2020-Like Drop

AMN Healthcare Services provides workforce and staffing solutions to healthcare facilities in the U.S. The company is relatively small with a market capitalization of less than $4 billion. However, small companies can make for excellent returns if one happens to identify the winners. And indeed, between late-2011 and early-2020, AMN stock from under $4 to…

Read More »

Zoetis Stock Getting Ahead of Itself, Invites Correction

Based in Parsippany, NJ, Zoetis Inc. is an animal medicine and vaccine developer and manufacturer. The company went public in 2013 and has been enjoying steady growth since. With the stock currently above $160 a share, Zoetis holds a market cap of nearly $80 billion. For a profitable and growing company like Zoetis, a rising…

Read More »

CBOE Stock Looking Good After a Record Year

CBOE Global Markets Inc. is an equities, options and futures exchange operator in the U.S. and Europe. The company traces its roots back to Chicago in 1973, when it practically invented options trading in its present form. CBOE is literally part of the very infrastructure of modern financial markets. So it is not surprising that…

Read More »

Novo Nordisk Bulls Have an Elliott Wave Problem

Novo Nordisk A/S is a Danish pharmaceuticals major with a market cap of over $160 billion. People need their medication even in recessions, so the company’s business wasn’t as affected by the 2020 crisis as most other industries. Novo Nordisk remains a top-notch pharma with consistent profits and revenue and no debt whatsoever. And the…

Read More »

More analyses